Reply: In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis

Inflamm Bowel Dis. 2024 Oct 3;30(10):1933. doi: 10.1093/ibd/izae181.
No abstract available

Publication types

  • Letter
  • Editorial
  • Comment

MeSH terms

  • Biological Products* / therapeutic use
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Treatment Outcome

Substances

  • Biological Products